Literature DB >> 12388147

Insulin action on protein metabolism in acromegalic patients.

Alberto Battezzati1, Stefano Benedini, Annalisa Fattorini, Marco Losa, Pietro Mortini, Simona Bertoli, Roberto Lanzi, Giulio Testolin, Gianni Biolo, Livio Luzi.   

Abstract

Insulin resistance in acromegaly causes glucose intolerance and diabetes, but it is unknown whether it involves protein metabolism, since both insulin and growth hormone promote protein accretion. The effects of acromegaly and of its surgical cure on the insulin sensitivity of glucose and amino acid/protein metabolism were evaluated by infusing [6,6-(2)H(2)]glucose, [1-(13)C]leucine, and [2-(15)N]glutamine during a euglycemic insulin (1 mU x kg(-1) x min(-1)) clamp in 12 acromegalic patients, six studied again 6 mo after successful adenomectomy, and eight healthy controls. Acromegalic patients, compared with postsurgical and control subjects, had higher postabsorptive glucose concentration (5.5 +/- 0.3 vs. 4.9 +/- 0.2 micromol/l, P < 0.05, and 5.1 +/- 0.1 micromol/l) and flux (2.7 +/- 0.1 vs. 2.0 +/- 0.2 micromol x kg(-1) x min(-1), P < 0.01, and 2.2 +/- 0.1 micromol x kg(-1) x min(-1), P < 0.05) and reduced insulin-stimulated glucose disposal (+15 +/- 9 vs. +151 +/- 18%, P < 0.01, and 219 +/- 58%, P < 0.001 from basal). Postabsorptive leucine metabolism was similar among groups. In acromegalic and postsurgical subjects, insulin suppressed less than in controls the endogenous leucine flux (-9 +/- 1 and -12 +/- 2 vs. -18 +/- 2%, P < 0.001 and P < 0.05), the nonoxidative leucine disposal (-4 +/- 3 and -1 +/- 3 vs. -18 +/- 2%, P < 0.01 and P < 0.05), respectively, indexes of proteolysis and protein synthesis, and leucine oxidation (-17 +/- 6% in postsurgical patients vs. -26 +/- 6% in controls, P < 0.05). Within 6 mo, surgery reverses insulin resistance for glucose but not for protein metabolism. After adenomectomy, more leucine is oxidized during hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388147     DOI: 10.1152/ajpendo.00020.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  5 in total

Review 1.  Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

Authors:  M G Baroni; F Giorgino; V Pezzino; C Scaroni; A Avogaro
Journal:  J Endocrinol Invest       Date:  2015-12-30       Impact factor: 4.256

2.  Alterations in body composition in acromegaly.

Authors:  Laurence Katznelson
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

3.  The acromegaly lipodystrophy.

Authors:  Pamela U Freda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

4.  Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly.

Authors:  Julia Szendroedi; Elisabeth Zwettler; Albrecht Ingo Schmid; Marek Chmelik; Giovanni Pacini; Gertrud Kacerovsky; Gerhard Smekal; Peter Nowotny; Oswald Wagner; Christoph Schnack; Guntram Schernthaner; Klaus Klaushofer; Michael Roden
Journal:  PLoS One       Date:  2008-12-18       Impact factor: 3.240

5.  Disposition Index in Active Acromegaly.

Authors:  Dan Alexandru Niculescu; Roxana Dusceac; Andra Caragheorgheopol; Nicoleta Popescu; Catalina Poiana
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.